SCHEMBL7019650

SCHEMBL7019650

Cc1ccc2c(c1)N=C/C2=C\C[N+](=O)[O-]

nearest known ligand 0.33

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 2/20 0.33
▸ CYP3A4 P08684 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13453375 0.72 HTR2C (0.36) —
SCHEMBL7019655 0.65 CA12 (0.37) TSHRCYP3A4
SCHEMBL29946198 0.62 MAOA (0.33) —
SCHEMBL11189916 0.58 TSHR (0.72) TSHRCYP3A4
SCHEMBL6818155 0.58 — —
SCHEMBL15199334 0.56 FBP1 (0.58) —
SCHEMBL23537533 0.56 CYP1A2 (0.41) CYP3A4
SCHEMBL4464974 0.56 TSHR (0.55) TSHRCYP3A4
SCHEMBL28662585 0.55 MAOA (0.42) —
SCHEMBL531072 0.53 ALDH1A1 (0.68) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0705832-B1 Serotonergic modulators LILLY CO ELI (GB) 2003-08-13 — — EP disclosed
US-5563147-A CENTRAL NERVOUS SYSTEM DISORDERS ELI LILLY AND COMPANY (US) 1996-10-08 — — US disclosed
EP-0705832-A1 Serotonergic modulators LILLY INDUSTRIES LIMITED (GB) 1996-04-10 — — EP disclosed
Send feedback